Cargando…
Intraperitoneal, subcutaneous and intravenous glucagon delivery and subsequent glucose response in rats: a randomized controlled crossover trial
OBJECTIVE: Hypoglycemia is a frequent and potentially dangerous event among patients with diabetes mellitus type 1. Subcutaneous glucagon is an emergency treatment to counteract severe hypoglycemia. The effect of intraperitoneal glucagon delivery is sparsely studied. We performed a direct comparison...
Autores principales: | Dirnena-Fusini, Ilze, Åm, Marte Kierulf, Fougner, Anders Lyngvi, Carlsen, Sven Magnus, Christiansen, Sverre Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235059/ https://www.ncbi.nlm.nih.gov/pubmed/30487972 http://dx.doi.org/10.1136/bmjdrc-2018-000560 |
Ejemplares similares
-
Intraperitoneal and subcutaneous glucagon delivery in anaesthetized pigs: effects on circulating glucagon and glucose levels
por: Åm, Marte Kierulf, et al.
Publicado: (2020) -
Intraperitoneal insulin administration in pigs: effect on circulating insulin and glucose levels
por: Dirnena-Fusini, Ilze, et al.
Publicado: (2021) -
Physiological effects of intraperitoneal versus subcutaneous insulin infusion in patients with diabetes mellitus type 1: A systematic review and meta-analysis
por: Dirnena-Fusini, Ilze, et al.
Publicado: (2021) -
Effect of sensor location on continuous intraperitoneal glucose sensing in an animal model
por: Åm, Marte Kierulf, et al.
Publicado: (2018) -
Pharmacokinetics of glucagon after intravenous, intraperitoneal and subcutaneous administration in a pig model
por: Teigen, Ingrid Anna, et al.
Publicado: (2022)